Novartis expects low single-digit decline in 2026 operating profit [Yahoo! Finance Canada]
Novartis AG (NVS)
Last novartis ag earnings: 4/28 01:00 am
Check Earnings Report
US:NYSE Investor Relations:
novartis.com/investors
Company Research
Source: Yahoo! Finance Canada
It also reported a 1% gain in ?fourth-quarter operating ?profit, which is adjusted for special items, on higher sales ?of breast cancer drug Kisqali, multiple sclerosis drug Kesimpta and psoriasis drug Cosentyx, among ?other drugs. The profit figure came in ?at $4.92 billion, in line with an analyst consensus of about $4.9 billion, compiled by Visible Alpha. Novartis is leaning on fast-growing cancer drugs Kisqali and Scemblix and ?its $30 billion acquisition ?and licensing push last ?year to address the impending patent cliff for some of its ?blockbuster drugs, ?including Entresto for heart failure, allergy shot Xolair and Cosentyx. (Reporting by ?Ludwig Burger in Frankfurt and Bhanvi Satija ?in London; Editing by Emelia Sithole-Matarise ?and Linda Pasquini)
Show less
Read more
Impact Snapshot
Event Time:
NVS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NVS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NVS alerts
High impacting Novartis AG news events
Weekly update
A roundup of the hottest topics
NVS
News
- Watch CNBC's full interview with Novartis' Vas Narasimhan [CNBC]CNBC
- Growth guidance remains fully intact,' says Novartis CEO Vas Narasimhan [CNBC]CNBC
- Novartis proposes dividend raise to CHF 3.70 [Seeking Alpha]Seeking Alpha
- Even Near an All-Time High, This Dividend ETF Looks Extremely Cheap [Yahoo! Finance]Yahoo! Finance
- Why Analysts Are Closely Watching Novartis AG (NVS) [Yahoo! Finance]Yahoo! Finance
NVS
Earnings
- 2/4/26 - Beat
NVS
Sec Filings
- 2/4/26 - Form S-8
- 2/4/26 - Form 6-K
- 2/4/26 - Form 6-K
- NVS's page on the SEC website